EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The significance of machine learning in neonatal screening for inherited metabolic diseases

Xiangchun Yang, Shuxia Ding, Jianping Zhang, Zhuojie Hu, Danyan Zhuang, Fei Wang, Shanshan Wu, Changshui Chen, Haibo Li

Frontiers in Pediatrics · 20.03.2024 · 12

DOI: 10.3389/fped.2024.1366891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 20.03.2024. Verfasst von Xiangchun Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Central Laboratory of Birth Defects Prevention and Control, Ningbo Women and Children's Hospital, Ningbo City, Zhejiang, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal screening for inherited metabolic diseases (IMDs) has been revolutionized by tandem mass spectrometry (MS/MS). This study aimed to enhance neonatal screening for IMDs using machine learning (ML) techniques.

Methods

The study involved the analysis of a comprehensive dataset comprising 309,102 neonatal screening records collected in the Ningbo region, China. An advanced ML system model, encompassing nine distinct algorithms, was employed for the purpose of predicting the presence of 31 different IMDs. The model was compared with traditional cutoff schemes to assess its diagnostic efficacy. Additionally, 180 suspected positive cases underwent further evaluation.

Results

The ML system exhibited a significantly reduced positive rate, from 1.17% to 0.33%, compared to cutoff schemes in the initial screening, minimizing unnecessary recalls and associated stress. In suspected positive cases, the ML system identified 142 true positives with high sensitivity (93.42%) and improved specificity (78.57%) compared to the cutoff scheme. While false negatives emerged, particularly in heterozygous carriers, our study revealed the potential of the ML system to detect asymptomatic cases.

Conclusion

This research provides valuable insights into the potential of ML in pediatric medicine for IMD diagnosis through neonatal screening, emphasizing the need for accurate carrier detection and further research in this domain.

Schlagwörter

Stichwörter der Autor:innen

carrierdiagnostic efficiencyinherited metabolic diseasesmachine learningneonatal screening

Autor:innen und Institutionen

  • The Central Laboratory of Birth Defects Prevention and Control, Ningbo Women and Children's Hospital, Ningbo City, Zhejiang, China.
  • Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
  • Department of Endocrinology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
  • Department of Children's Healthcare Clinic, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Paediatric Surgery Centre, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Zitieren

APA

Yang, X., Ding, S., Zhang, J., Hu, Z., Zhuang, D., Wang, F., Wu, S., Chen, C., & Li, H. (2024). The significance of machine learning in neonatal screening for inherited metabolic diseases. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1366891

Vancouver

Yang X, Ding S, Zhang J, Hu Z, Zhuang D, Wang F, et al. The significance of machine learning in neonatal screening for inherited metabolic diseases. Frontiers in Pediatrics. 2024;12. doi:10.3389/fped.2024.1366891

BibTeX
@article{Yang2024,
  author = {Yang, Xiangchun and Ding, Shuxia and Zhang, Jianping and Hu, Zhuojie and Zhuang, Danyan and Wang, Fei and Wu, Shanshan and Chen, Changshui and Li, Haibo},
  title = {The significance of machine learning in neonatal screening for inherited metabolic diseases},
  journal = {Frontiers in Pediatrics},
  year = {2024},
  volume = {12},
  doi = {10.3389/fped.2024.1366891}
}
Kostenlos starten →